Activities of Sabine WILS related to 2013/0150(COD)
Shadow reports (1)
REPORT on the proposal for a regulation of the European Parliament and of the Council amending Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products with regard to certain conditions for access to the market PDF (258 KB) DOC (338 KB)
Amendments (5)
Amendment 23 #
Proposal for a regulation
Recital 7 a (new)
Recital 7 a (new)
(7a) In order for the system established by this Regulation to operate effectively, there should be good cooperation, coordination and exchange of information between the Member States, the Agency and the Commission regarding enforcement.
Amendment 37 #
Proposal for a regulation
Article 1 – point 8 a (new)
Article 1 – point 8 a (new)
Regulation 528/2012/EU
Article 74 – paragraph 2
Article 74 – paragraph 2
Amendment 40 #
Proposal for a regulation
Article 1 – point 8 b (new)
Article 1 – point 8 b (new)
(8b) (ka) providing support and assistance to Member States with regard to control and enforcement activities.
Amendment 43 #
Proposal for a regulation
Article 1 – point 9 a (new)
Article 1 – point 9 a (new)
Regulation 528/2012/EU
Article 78 – paragraph 2 – subparagraph 2
Article 78 – paragraph 2 – subparagraph 2
(9a) In Article 78(2), the second subparagraph shall be replaced by the following: "Revenue of the Agency referred to in Article 96(1) of Regulation (EC) No 1907/2006 shall not be used for carrying out tasks under this Regulation, unless it is for a joint purpose. Revenue of the Agency referred to in paragraph 1 of this Article shall not be used for carrying out tasks under Regulation (EC) No 1907/2006., unless it is for a joint purpose."
Amendment 51 #
Proposal for a regulation
Article 1 – point 13
Article 1 – point 13
Regulation 528/2012/EU
Article 95 – paragraph 7 a (new)
Article 95 – paragraph 7 a (new)
7a. Following the renewal of the approval of an active substance, any substance supplier or product supplier may submit to the Agency a letter of access to all the data which was considered by the evaluating competent authority as relevant for the purpose of the renewal, and for which the protection period has not yet expired (the 'relevant data'). Following the renewal of the approval of an active substance, the Agency shall remove from the list referred to in paragraph 1 any substance supplier or product supplier included therein who has not within 6 months from the renewal submitted all the relevant data or a letter of access to all the relevant data, either in accordance with the second subparagraph of paragraph 1 or in an application in accordance with Article 13.